Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2016-07-20, 11:47:43 | version 1.38.0
Inplant Tribune United Kingdom Edition | 6/2016 IMPLANT BUSINESS AD From 23 to 26 June, Nobel Biocare held its global symposium in the world metropolis of New York in the US.The company staged a truly exceptional event with a high-class educational programme at the Waldorf Astoria in Manhattan. As the official media partner of the event, Dental Tribune International had the opportunity to meet with Hans Geiselhöringer, President of Nobel Biocare and Dental Imaging, at the symposium for a short inter- view. Dental Tribune International: Has the global symposium met your expectations? Hans Geiselhöringer: We are extremely happy with the sympo- sium because it has exceeded our expectations in every sense, from the record number of participants to the motivation of our team and customers to engage in discus- sions, as well as the quality of the speakers and their presentations. We have always had high stand- ards at our meetings, but I must say that I was really thrilled by the way innovation was presented not only by our company but also by the clinicians and experts themselves. In addition, I found the NEXT GEN forum in particular incredi- ble, as it gave us confirmation that we are on the right track to doing more for the younger generation of implantologists. I was positively surprised to see how enthusiastic and open our young clinicians are to working hard with us to move this project forward. Overall, we have seen at this symposium that the future is bright, and I strongly disagree with some critical voices that sug- gest that there will no longer be real innovations in implantology. In my opinion, the journey of innovating the clinical workflow has just begun. With regard to training of the next generation of dental professionals, what kind of role can or should Nobel Biocare play in implant edu- cation? “The journey of innovating the clinical workflow has just begun” An interview with Nobel Biocare and Digital Imaging President Hans Geiselhöringer Hans Geiselhöringer ” Page 23 “I believe that even experts cannot predict the impact of the Brexit on the industry.”